Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome

NCT: NCT07151248 · RECRUITING

NCT IDNCT07151248
StatusRECRUITING
Start Date2025-09-26
Completion2029-09

Brief Summary

The main goal of the proposed study is to critically evaluate a nonpharmacological and readily available therapy, cranial electrical stimulation (CES) using Alpha-Stim™, and to discover the brain function mechanisms underlying Gulf War Illness-related Headache and Pain (GWI-HAP) and treatment response to CES. For this objective, the investigators will employ an adaptive trial design as well as a neuroimaging technique using MRI, which has become the pre-eminent technique for assessing the integrity of brain function, connectivity, and organization in healthy brain and pathology.

Frequently Asked Questions

What is Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome?

Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome is a clinical trial registered under NCT07151248. Current status: RECRUITING.

What is the status of NCT07151248?

The current status of NCT07151248 (Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome) is: RECRUITING.

When did Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome start?

Cranial Electrotherapy Stimulation and Brain Imaging for Gulf War Syndrome started on 2025-09-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.